Expression of interleukin-2 in Candidal balanoposthitis and its clinical significance.
Chen J, Zhou YX, Jin XD, Chen SW.
Chin Med J (Engl). 2011 Sep;124(17):2776-8.
PMID:22040441
Severe candidal balanoposthitis on concurrent treatment with secukinumab and the antidiabetic agent empagliflozin (sodium-glucose cotransporter 2 inhibitor - SGLT2-inhibitor).
Moldenhauer I, Pliquett RU, Kreft B, Sunderkötter C.